Mysimba Article-20 procedure - Timetable for the procedure
Submitted by Anonymous (not verified) on 1 July 2024 - 15:04
Mysimba Article-20 procedure - Timetable for the procedure
Annual accounts: Financial year 2023
Submitted by Anonymous (not verified) on 1 July 2024 - 12:52
Annual accounts: Financial year 2023
Clinical investigation of medicinal products for the treatment of psoriatic arthritis - Scientific guideline
Submitted by Anonymous (not verified) on 1 July 2024 - 7:01
Clinical investigation of medicinal products for the treatment of psoriatic arthritis - Scientific guideline
Concept paper on the need for revision of the guideline on clinical investigation of medicinal products for the treatment of psoriatic arthritis
Submitted by Anonymous (not verified) on 1 July 2024 - 7:00
Concept paper on the need for revision of the guideline on clinical investigation of medicinal products for the treatment of psoriatic arthritis
Concept paper on the need for revision of the guideline on clinical investigation of medicinal products for the treatment of psoriatic arthritis
Submitted by Anonymous (not verified) on 1 July 2024 - 7:00
Concept paper on the need for revision of the guideline on clinical investigation of medicinal products for the treatment of psoriatic arthritis
Policy 1: Quality Management Policy
Submitted by Anonymous (not verified) on 1 July 2024 - 0:00
Policy 1: Quality Management Policy
Veterinary medicines European public assessment report (EPAR): Palladia, toceranib, Status: Authorised
Submitted by Anonymous (not verified) on 28 June 2024 - 21:58
Veterinary medicines European public assessment report (EPAR): Palladia, toceranib, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Zuprevo, tildipirosin, Status: Authorised
Submitted by Anonymous (not verified) on 28 June 2024 - 21:30
Veterinary medicines European public assessment report (EPAR): Zuprevo, tildipirosin, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Ypozane, osaterone acetate, Status: Authorised
Submitted by Anonymous (not verified) on 28 June 2024 - 21:18
Veterinary medicines European public assessment report (EPAR): Ypozane, osaterone acetate, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Zactran, gamithromycin, Status: Authorised
Submitted by Anonymous (not verified) on 28 June 2024 - 19:47
Veterinary medicines European public assessment report (EPAR): Zactran, gamithromycin, Status: Authorised